Dataset Information

FNBtools: A Software to Identify Homozygous Lesions in Deletion Mutant Populations.

ABSTRACT: Deletion mutagenesis such as fast neutron bombardment (FNB) has been widely used for forward and reverse genetics studies in functional genomics. Traditionally, the time-consuming map-based cloning is used to locate causal deletions in deletion mutants. In recent years, comparative genomic hybridization (CGH) has been used to speed up and scale up the lesion identification process in deletion mutants. However, limitations of low accuracy and sensitivity for small deletions in the CGH approach are apparent. With the next generation sequencing (NGS) becoming affordable for most users, NGS-based bioinformatics tools are more appealing. Although several deletion callers are available, these tools are not efficient in detecting small deletions. Population-scale deletion callers that can identify both small and large deletions are rare. We were motivated to create a population-scale deletion detection tool, called FNBtools, to identify homozygous causal deletions in mutant populations by using NGS data. FNBtools is a tool to call deletions at a population-scale and to achieve high accuracy at different levels of coverage. In addition, FNBtools can detect both small and large deletions with the ability to identify unique deletions in a mutant pool by filtering deletions that exist in a wild-type or control pool. Furthermore, FNBtools is also able to visualize all identified deletions in a genome-wide scope by using Circos. From simulated data analysis, FNBtools outperforms four existing popular deletion callers in detecting small deletions at different coverage levels. To test the usefulness of FNBtools in real biological applications, we used it to analyze a salt-tolerant mutant in Medicago truncatula and identified the unique deletion locus that is tightly linked with this trait. The causal deletion in the mutant was confirmed by PCR amplification, sequencing and genetic linkage analyses. FNBtools can be used for homozygous deletion identification in any species with reference genome sequences. FNBtools is publicly available at: https://github.com/noble-research-institute/fnbtools.

SUBMITTER: Sun L

PROVIDER: S-EPMC6048286 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

FNBtools: A Software to Identify Homozygous Lesions in Deletion Mutant Populations.

Sun Liang L Ge Yinbing Y Bancroft Andrew Charles AC Cheng Xiaofei X Wen Jiangqi J

Frontiers in plant science 20180710

Deletion mutagenesis such as fast neutron bombardment (FNB) has been widely used for forward and reverse genetics studies in functional genomics. Traditionally, the time-consuming map-based cloning is used to locate causal deletions in deletion mutants. In recent years, comparative genomic hybridization (CGH) has been used to speed up and scale up the lesion identification process in deletion mutants. However, limitations of low accuracy and sensitivity for small deletions in the CGH approach ar ...[more]

PMID: 30042776

Similar Datasets

Project description:BACKGROUND:The 2016 World Health Organization (WHO) classification of central nervous system tumors stratifies isocitrate dehydrogenase (IDH)-mutant gliomas into 2 major groups depending on the presence or absence of 1p/19q codeletion. However, the grading system remains unchanged and it is now controversial whether it can be still applied to this updated molecular classification. METHODS:In a large cohort of 911 high-grade IDH-mutant gliomas from the French national POLA network (including 428 IDH-mutant gliomas without 1p/19q codeletion and 483 anaplastic oligodendrogliomas, IDH-mutant and 1p/19q codeleted), we investigated the prognostic value of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene homozygous deletion as well as WHO grading criteria (mitoses, microvascular proliferation, and necrosis). In addition, we searched for other retinoblastoma pathway gene alterations (CDK4 amplification and RB1 homozygous deletion) in a subset of patients. CDKN2A homozygous deletion was also searched in an independent series of 40 grade II IDH-mutant gliomas. RESULTS:CDKN2A homozygous deletion was associated with dismal outcome among IDH-mutant gliomas lacking 1p/19q codeletion (P < 0.0001 for progression-free survival and P = 0.004 for overall survival) as well as among anaplastic oligodendrogliomas, IDH-mutant + 1p/19q codeleted (P = 0.002 for progression-free survival and P < 0.0001 for overall survival) in univariate and multivariate analysis including age, extent of surgery, adjuvant treatment, microvascular proliferation, and necrosis. In both groups, the presence of microvascular proliferation and/or necrosis remained of prognostic value only in cases lacking CDKN2A homozygous deletion. CDKN2A homozygous deletion was not recorded in grade II gliomas. CONCLUSIONS:Our study pointed out the utmost relevance of CDKN2A homozygous deletion as an adverse prognostic factor in the 2 broad categories of IDH-mutant gliomas stratified on 1p/19q codeletion and suggests that the grading of these tumors should be refined.

Project description:ObjectiveCyclin-dependent kinase inhibitor (CDKN)2A/B homozygous deletion is a key molecular marker of isocitrate dehydrogenase (IDH)-mutant astrocytomas in the 2021 World Health Organization. We aimed to investigate whether qualitative and quantitative MRI parameters can predict CDKN2A/B homozygous deletion status in IDH-mutant astrocytomas.Materials and methodsPreoperative MRI data of 88 patients (mean age ± standard deviation, 42.0 ± 11.9 years; 40 females and 48 males) with IDH-mutant astrocytomas (76 without and 12 with CDKN2A/B homozygous deletion) from two institutions were included. A qualitative imaging assessment was performed. Mean apparent diffusion coefficient (ADC), 5th percentile of ADC, mean normalized cerebral blood volume (nCBV), and 95th percentile of nCBV were assessed via automatic tumor segmentation. Logistic regression was performed to determine the factors associated with CDKN2A/B homozygous deletion in all 88 patients and a subgroup of 47 patients with histological grades 3 and 4. The discrimination performance of the logistic regression models was evaluated using the area under the receiver operating characteristic curve (AUC).ResultsIn multivariable analysis of all patients, infiltrative pattern (odds ratio [OR] = 4.25, p = 0.034), maximal diameter (OR = 1.07, p = 0.013), and 95th percentile of nCBV (OR = 1.34, p = 0.049) were independent predictors of CDKN2A/B homozygous deletion. The AUC, accuracy, sensitivity, and specificity of the corresponding model were 0.83 (95% confidence interval [CI], 0.72-0.91), 90.4%, 83.3%, and 75.0%, respectively. On multivariable analysis of the subgroup with histological grades 3 and 4, infiltrative pattern (OR = 10.39, p = 0.012) and 95th percentile of nCBV (OR = 1.24, p = 0.047) were independent predictors of CDKN2A/B homozygous deletion, with an AUC accuracy, sensitivity, and specificity of the corresponding model of 0.76 (95% CI, 0.60-0.88), 87.8%, 80.0%, and 58.1%, respectively.ConclusionThe presence of an infiltrative pattern, larger maximal diameter, and higher 95th percentile of the nCBV may be useful MRI biomarkers for CDKN2A/B homozygous deletion in IDH-mutant astrocytomas.

Project description:IDH-mutant astrocytomas have a more indolent natural history and better prognosis than their IDH-wild type counterparts, but are still graded according to schemes developed prior to the recognition of this type of neoplasm as a distinct entity. Homozygous deletion of CDKN2A has been proposed as a molecular correlate of aggressive behavior in these tumors, and may be incorporated into future grading systems in an effort to improve prognostic stratification. Fluorescence in situ hybridization (FISH) is a common ancillary testing modality used to assess CDKN2A status, but the specifics of how to best interpret FISH results for prognostication of gliomas have not been clearly defined in the literature. To address this issue, we performed a retrospective analysis of prospectively collected CDKN2A FISH data from 108 primary and 43 recurrent IDH-mutant astrocytomas diagnosed between 2007-2020 at the University of Pittsburgh Medical Center. High level CDKN2A homozygous deletion was rare in primary tumors and was identified more frequently in recurrent tumors. Multivariate Cox Proportional-Hazards analysis demonstrated that histologic grade and CDKN2A status are independent predictors of survival, and the prognostic value of CDKN2A is maximized by applying a threshold of???30% of tumor cells with homozygous deletion by FISH to define a positive result. At this threshold, CDKN2A deletion significantly stratified survival of histologic grade 4 tumors, but grade 2 and 3 tumors rarely exceeded this cutoff value and did not show worse survival. Lower thresholds identified additional lower grade tumors, but were not prognostically useful. Compared to prior studies, the lack of prognostic significance of CDKN2A homozygous deletion by FISH in grade 2-3 IDH-mutant astrocytomas may reflect differences in cohort populations or technical differences between testing modalities. Definitive criteria for determining CDKN2A homozygous deletion by various methodologies will be critical if this is to be included in future grading schemes.

Dataset Information

FNBtools: A Software to Identify Homozygous Lesions in Deletion Mutant Populations.

Publications

FNBtools: A Software to Identify Homozygous Lesions in Deletion Mutant Populations.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets